New Oxford University Malaria vaccine receives regulatory approval in Ghana modernghana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernghana.com Daily Mail and Mail on Sunday newspapers.
The R21/Matrix-M vaccine, leveraging Novavax s adjuvant technology, has been approved for use by Africa s Food and Drugs Authority in Ghana for children aged 5 to 36 months - the age group at the highest risk of death from malaria.
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority The R21/Matrix-M™ malaria vaccine, developed by the University of Oxford, leveraging an adjuvant…